Natixis Advisors, L.P. Becton Dickinson & CO Transaction History
Natixis Advisors, L.P.
- $68.5 Billion
- Q3 2025
A detailed history of Natixis Advisors, L.P. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Natixis Advisors, L.P. holds 307,541 shares of BDX stock, worth $58.7 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
307,541
Previous 170,683
80.18%
Holding current value
$58.7 Million
Previous $29.4 Million
95.79%
% of portfolio
0.08%
Previous 0.05%
Shares
33 transactions
Others Institutions Holding BDX
# of Institutions
1,718Shares Held
257MCall Options Held
1.01MPut Options Held
544K-
Vanguard Group Inc Valley Forge, PA32.5MShares$6.2 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY22.3MShares$4.25 Billion0.12% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$3.1 Billion1.86% of portfolio
-
State Street Corp Boston, MA13.9MShares$2.65 Billion0.09% of portfolio
-
First Eagle Investment Management, LLC9.99MShares$1.91 Billion3.54% of portfolio
About BECTON DICKINSON & CO
- Ticker BDX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 285,195,008
- Market Cap $54.5B
- Description
- Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...